Zumutor Biologics

Zumutor Biologics

Biotechnology Research

Cambridge, MA 6,538 followers

A leading Immuno Oncology company in the space of NK cell therapeutics

About us

At Zumutor, we are on a mission to develop novel novel immuno onco-therapeutics that drive transformational improvements in cancer treatment through NK cell engagement. We leverage our proven proprietary antibody discovery- INABLR™ for fast track Antibody discovery and development. Our team works in collaboration with a world class Scientific Advisory Board with expertise in immuno-oncology and clinical development. Our lead asset (ZM008) is a first-in-class antibody that targets certain receptors that blocks NK cell inhibitory signal and enables NK cell activation to generate a potent immune response. Development is on track for an IND filing by Q2 2022 and Phase 1 clinical trial thereafter. We are headquartered in CIC Cambridge Campus, MA and R&D is carried out at ISO certified lab in Bangalore, India

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Cambridge, MA
Type
Privately Held
Founded
2015
Specialties
Immuno-oncology, Biologics, Antibody Display

Locations

  • Primary

    Zumutor Biologics Inc

    CIC Cambridge Campus, 1 Broadway,

    Cambridge, MA 02142, US

    Get directions
  • Zumutor Biologics Pvt Ltd

    #118/119, Ground Floor, Prasad Enclave, Yeshwanthpur Industrial Suburb 2nd stage,5th main, Yeshwanthpur

    Bangalore, Karnataka 560022, IN

    Get directions

Employees at Zumutor Biologics

Updates

Similar pages

Browse jobs

Funding